Exact Mass: 688.615798

Exact Mass Matches: 688.615798

Found 198 metabolites which its exact mass value is equals to given mass value 688.615798, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

DG(22:1n9/0:0/18:2n6)

(2R)-2-Hydroxy-3-[(9Z,12Z)-nonadeca-9,12-dienoyloxy]propyl (13Z)-docos-13-enoic acid

C44H80O5 (688.600543)


DG(22:1n9/0:0/18:2n6) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at the C-1, C-2, or C-3 positions. DG(22:1n9/0:0/18:2n6), in particular, consists of one chain of erucic acid at the C-1 position and one chain of linoleic acid at the C-3 position. The erucic acid moiety is derived from seed oils and avocados, while the linoleic acid moiety is derived from seed oils. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.
Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.
Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-3 position.

   

CE(11:1D3)

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (E)-11-(3,4-dimethyl-5-propylfuran-2-yl)undec-10-enoate

C47H76O3 (688.5794146)


CE(11:1D3) is an unsaturated furan fatty acid ester of cholesterol or simply a cholesteryl ester (CE). Cholesteryl esters are much less polar than free cholesterol and appear to be the preferred form for transport in plasma and for storage. Cholesteryl esters do not contribute to membranes but are packed into intracellular lipid particles or lipoprotein particles. Because of the mechanism of synthesis, plasma cholesteryl esters tend to contain relatively high proportions of C18 fatty acids. Cholesteryl esters are major constituents of the adrenal glands and they also accumulate in the fatty lesions of atherosclerotic plaques. Cholesteryl esters are also major constituents of the lipoprotein particles carried in blood (HDL, LDL, VLDL). The cholesteryl esters in high-density lipoproteins (HDL) are synthesized largely by transfer of fatty acids to cholesterol from position sn-2 (or C-2) of phosphatidylcholine catalyzed by the enzyme lecithin cholesterol acyl transferase (LCAT). The enzyme also promotes the transfer of cholesterol from cells to HDL. As cholesteryl esters accumulate in the lipoprotein core, cholesterol is removed from its surface thus promoting the flow of cholesterol from cell membranes into HDL. This in turn leads to morphological changes in HDL, which grow and become spherical. Subsequently, cholesteryl esters are transferred to the other lipoprotein fractions LDL and VLDL, a reaction catalyzed by cholesteryl ester transfer protein. Another enzyme, acyl-CoA:cholesterol acyltransferase (ACAT) synthesizes cholesteryl esters from CoA esters of fatty acids and cholesterol. Cholesteryl ester hydrolases liberate cholesterol and free fatty acids when required for membrane and lipoprotein formation, and they also provide cholesterol for hormone synthesis in adrenal cells. The shorthand notation for CE(11:1D3) refers to the furan fatty acids 11-carbon carboxyalkenyl moiety, the dimethyl substitutions in the 3- and 4-positions of its furan moiety, and its 3-carbon alkyl moiety.

   

CE(11D3:1)

[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 11-[3,4-dimethyl-5-[(E)-prop-1-enyl]furan-2-yl]undecanoate

C47H76O3 (688.5794146)


CE(11D3:1) is an unsaturated furan fatty acid ester of cholesterol or simply a cholesteryl ester (CE). Cholesteryl esters are much less polar than free cholesterol and appear to be the preferred form for transport in plasma and for storage. Cholesteryl esters do not contribute to membranes but are packed into intracellular lipid particles or lipoprotein particles. Because of the mechanism of synthesis, plasma cholesteryl esters tend to contain relatively high proportions of C18 fatty acids. Cholesteryl esters are major constituents of the adrenal glands and they also accumulate in the fatty lesions of atherosclerotic plaques. Cholesteryl esters are also major constituents of the lipoprotein particles carried in blood (HDL, LDL, VLDL). The cholesteryl esters in high-density lipoproteins (HDL) are synthesized largely by transfer of fatty acids to cholesterol from position sn-2 (or C-2) of phosphatidylcholine catalyzed by the enzyme lecithin cholesterol acyl transferase (LCAT). The enzyme also promotes the transfer of cholesterol from cells to HDL. As cholesteryl esters accumulate in the lipoprotein core, cholesterol is removed from its surface thus promoting the flow of cholesterol from cell membranes into HDL. This in turn leads to morphological changes in HDL, which grow and become spherical. Subsequently, cholesteryl esters are transferred to the other lipoprotein fractions LDL and VLDL, a reaction catalyzed by cholesteryl ester transfer protein. Another enzyme, acyl-CoA:cholesterol acyltransferase (ACAT) synthesizes cholesteryl esters from CoA esters of fatty acids and cholesterol. Cholesteryl ester hydrolases liberate cholesterol and free fatty acids when required for membrane and lipoprotein formation, and they also provide cholesterol for hormone synthesis in adrenal cells. The shorthand notation for CE(11D3:1) refers to the furan fatty acids 11-carbon carboxyalkyl moiety, the dimethyl substitutions in the 3- and 4-positions of its furan moiety, and its 3-carbon alkenyl moiety.

   

DG(22:1(13Z)/19:2(10Z,13Z)/0:0)

(2S)-3-Hydroxy-2-[(10Z,13Z)-nonadeca-10,13-dienoyloxy]propyl (13Z)-docos-13-enoic acid

C44H80O5 (688.600543)


Diglycerides (DGs) are also known as diacylglycerols or diacylglycerides, meaning that they are glycerides consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. DG(22:1(13Z)/19:2(10Z,13Z)/0:0), in particular, consists of one chain of erucic acid at the C-1 position and one chain of (10Z,13Z)-nonadecadienoic acid at the C-2 position. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Diacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections.

   

CE(20:3(5Z,8Z,11Z)-O(14R,15S))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,11Z)-13-(3-pentyloxiran-2-yl)trideca-5,8,11-trienoate

C47H76O3 (688.5794146)


CE(20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:3(5Z,8Z,11Z)-O(14R,15S)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:3(5Z,8Z,14Z)-O(11S,12R))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z)-10-{3-[(2Z)-oct-2-en-1-yl]oxiran-2-yl}deca-5,8-dienoate

C47H76O3 (688.5794146)


CE(20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:3(5Z,8Z,14Z)-O(11S,12R)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:3(5Z,11Z,14Z)-O(8,9))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z)-7-{3-[(2Z,5Z)-undeca-2,5-dien-1-yl]oxiran-2-yl}hept-5-enoate

C47H76O3 (688.5794146)


CE(20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:3(5Z,11Z,14Z)-O(8,9)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:3(8Z,11Z,14Z)-O(5,6))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl 4-{3-[(2Z,5Z,8Z)-tetradeca-2,5,8-trien-1-yl]oxiran-2-yl}butanoate

C47H76O3 (688.5794146)


CE(20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:3(8Z,11Z,14Z)-O(5,6)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:4(5Z,8Z,11Z,14Z)-OH(20))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,11Z,14Z)-20-hydroxyicosa-5,8,11,14-tetraenoate

C47H76O3 (688.5794146)


CE(20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(5Z,8Z,11Z,14Z)-OH(20)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:4(6E,8Z,11Z,14Z)-OH(5S))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5S,6E,8Z,11Z,14Z)-5-hydroxyicosa-6,8,11,14-tetraenoate

C47H76O3 (688.5794146)


CE(20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(6E,8Z,11Z,14Z)-OH(5S)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:4(5Z,8Z,11Z,14Z)-OH(19S))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,11Z,14Z,19R)-19-hydroxyicosa-5,8,11,14-tetraenoate

C47H76O3 (688.5794146)


CE(20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(5Z,8Z,11Z,14Z)-OH(19S)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:4(5Z,8Z,11Z,14Z)-OH(18R))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,11Z,14Z,18S)-18-hydroxyicosa-5,8,11,14-tetraenoate

C47H76O3 (688.5794146)


CE(20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(5Z,8Z,11Z,14Z)-OH(18R)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:4(5Z,8Z,11Z,14Z)-OH(17))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,11Z,14Z)-17-hydroxyicosa-5,8,11,14-tetraenoate

C47H76O3 (688.5794146)


CE(20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(5Z,8Z,11Z,14Z)-OH(17)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:4(5Z,8Z,11Z,14Z)-OH(16R))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,11Z,14Z,16S)-16-hydroxyicosa-5,8,11,14-tetraenoate

C47H76O3 (688.5794146)


CE(20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(5Z,8Z,11Z,14Z)-OH(16R)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:4(5Z,8Z,11Z,13E)-OH(15S))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,11Z,13E,15R)-15-hydroxyicosa-5,8,11,13-tetraenoate

C47H76O3 (688.5794146)


CE(20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(5Z,8Z,11Z,13E)-OH(15S)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:4(5Z,8Z,10E,14Z)-OH(12S))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5Z,8Z,10E,12R,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoate

C47H76O3 (688.5794146)


CE(20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(5Z,8Z,10E,14Z)-OH(12S)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:4(5E,8Z,12Z,14Z)-OH(11R))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5E,8Z,11S,12Z,14Z)-11-hydroxyicosa-5,8,12,14-tetraenoate

C47H76O3 (688.5794146)


CE(20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(5E,8Z,12Z,14Z)-OH(11R)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

CE(20:4(5Z,7E,11Z,14Z)-OH(9))

(1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl (5E,7Z,11Z,14Z)-9-hydroxyicosa-5,7,11,14-tetraenoate

C47H76O3 (688.5794146)


CE(20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of cholesteryl esters, whose structure is characetized by a cholesterol esterified at the 3-position with a fatty acid. A cholesteryl ester is an ester of cholesterol. Fatty acid esters of cholesterol constitute about two-thirds of the cholesterol in the plasma. Cholesterol is a sterol (a combination steroid and alcohol) and a lipid found in the cell membranes of all body tissues, and transported in the blood plasma of all animals. The accumulation of cholesterol esters in the arterial intima (the innermost layer of an artery, in direct contact with the flowing blood) is a characteristic feature of atherosclerosis. Atherosclerosis is a disease affecting arterial blood vessels. It is a chronic inflammatory response in the walls of arteries, in large part to the deposition of lipoproteins (plasma proteins that carry cholesterol and triglycerides). CE(20:4(5Z,7E,11Z,14Z)-OH(9)) may also accumulate in hereditary hypercholesterolemia, an inborn error of metabolism.

   

O-(9Z,12Z-Octadecadienoyl) -3beta-12-Oleanen-3-ol

O-(9Z,12Z-Octadecadienoyl) -3beta-12-Oleanen-3-ol

C48H80O2 (688.615798)


   

??-Amyrin linoleate

??-Amyrin linoleate

C48H80O2 (688.615798)


   

20:3 Campesteryl ester

Campest-5-en-3beta-yl (11Z,14Z,17Z-eicosadienoate)

C48H80O2 (688.615798)


   

DG(19:0/22:3/0:0)[iso2]

1-nonadecanoyl-2-(10Z,13Z,16Z-docosatrienoyl)-sn-glycerol

C44H80O5 (688.600543)


   

DG(20:3/21:0/0:0)[iso2]

1-(8Z,11Z,14Z-eicosatrienoyl)-2-heneicosanoyl-sn-glycerol

C44H80O5 (688.600543)


   

DG(19:1(9Z)/22:2(13Z,16Z)/0:0)[iso2]

1-9Z-nonadecenoyl-2-(13Z,16Z-docosadienoyl)-sn-glycerol

C44H80O5 (688.600543)


   

DG 41:3

1-(8Z,11Z,14Z-eicosatrienoyl)-2-heneicosanoyl-sn-glycerol

C44H80O5 (688.600543)


   

20:3 Campesterol ester

Campest-5-en-3beta-yl (11Z,14Z,17Z-eicosadienoate)

C48H80O2 (688.615798)


   

CE(20:4(6E,8Z,11Z,14Z)-OH(5S))

CE(20:4(6E,8Z,11Z,14Z)-OH(5S))

C47H76O3 (688.5794146)


   

CE(20:4(5Z,7E,11Z,14Z)-OH(9))

CE(20:4(5Z,7E,11Z,14Z)-OH(9))

C47H76O3 (688.5794146)


   

CE(20:3(5Z,8Z,11Z)-O(14R,15S))

CE(20:3(5Z,8Z,11Z)-O(14R,15S))

C47H76O3 (688.5794146)


   

CE(20:3(5Z,8Z,14Z)-O(11S,12R))

CE(20:3(5Z,8Z,14Z)-O(11S,12R))

C47H76O3 (688.5794146)


   

CE(20:3(5Z,11Z,14Z)-O(8,9))

CE(20:3(5Z,11Z,14Z)-O(8,9))

C47H76O3 (688.5794146)


   

CE(20:3(8Z,11Z,14Z)-O(5,6))

CE(20:3(8Z,11Z,14Z)-O(5,6))

C47H76O3 (688.5794146)


   

CE(20:4(5Z,8Z,11Z,14Z)-OH(20))

CE(20:4(5Z,8Z,11Z,14Z)-OH(20))

C47H76O3 (688.5794146)


   

CE(20:4(5Z,8Z,11Z,14Z)-OH(19S))

CE(20:4(5Z,8Z,11Z,14Z)-OH(19S))

C47H76O3 (688.5794146)


   

CE(20:4(5Z,8Z,11Z,14Z)-OH(18R))

CE(20:4(5Z,8Z,11Z,14Z)-OH(18R))

C47H76O3 (688.5794146)


   

CE(20:4(5Z,8Z,11Z,14Z)-OH(17))

CE(20:4(5Z,8Z,11Z,14Z)-OH(17))

C47H76O3 (688.5794146)


   

CE(20:4(5Z,8Z,11Z,14Z)-OH(16R))

CE(20:4(5Z,8Z,11Z,14Z)-OH(16R))

C47H76O3 (688.5794146)


   

CE(20:4(5Z,8Z,11Z,13E)-OH(15S))

CE(20:4(5Z,8Z,11Z,13E)-OH(15S))

C47H76O3 (688.5794146)


   

CE(20:4(5Z,8Z,10E,14Z)-OH(12S))

CE(20:4(5Z,8Z,10E,14Z)-OH(12S))

C47H76O3 (688.5794146)


   

CE(20:4(5E,8Z,12Z,14Z)-OH(11R))

CE(20:4(5E,8Z,12Z,14Z)-OH(11R))

C47H76O3 (688.5794146)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[1-hydroxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

[1-hydroxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C45H84O4 (688.6369264)


   

(1-hexadecoxy-3-hydroxypropan-2-yl) (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

(1-hexadecoxy-3-hydroxypropan-2-yl) (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

C45H84O4 (688.6369264)


   

[1-[(Z)-henicos-11-enoxy]-3-hydroxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

[1-[(Z)-henicos-11-enoxy]-3-hydroxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C45H84O4 (688.6369264)


   

[1-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-3-hydroxypropan-2-yl] icosanoate

[1-[(10Z,13Z,16Z)-docosa-10,13,16-trienoxy]-3-hydroxypropan-2-yl] icosanoate

C45H84O4 (688.6369264)


   

(1-docosoxy-3-hydroxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate

(1-docosoxy-3-hydroxypropan-2-yl) (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C45H84O4 (688.6369264)


   

[1-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]-3-hydroxypropan-2-yl] hexadecanoate

[1-[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoxy]-3-hydroxypropan-2-yl] hexadecanoate

C45H84O4 (688.6369264)


   

(1-hydroxy-3-tetracosoxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

(1-hydroxy-3-tetracosoxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C45H84O4 (688.6369264)


   

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

[1-[(Z)-hexadec-9-enoxy]-3-hydroxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C45H84O4 (688.6369264)


   

[1-hydroxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propan-2-yl] tetradecanoate

[1-hydroxy-3-[(14Z,17Z,20Z)-octacosa-14,17,20-trienoxy]propan-2-yl] tetradecanoate

C45H84O4 (688.6369264)


   

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

[1-hydroxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

C45H84O4 (688.6369264)


   

[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] (Z)-icos-11-enoate

[1-[(13Z,16Z)-docosa-13,16-dienoxy]-3-hydroxypropan-2-yl] (Z)-icos-11-enoate

C45H84O4 (688.6369264)


   

[1-[(Z)-hexacos-15-enoxy]-3-hydroxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

[1-[(Z)-hexacos-15-enoxy]-3-hydroxypropan-2-yl] (9Z,12Z)-hexadeca-9,12-dienoate

C45H84O4 (688.6369264)


   

(1-hydroxy-3-icosoxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate

(1-hydroxy-3-icosoxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C45H84O4 (688.6369264)


   

(1-hexacosoxy-3-hydroxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

(1-hexacosoxy-3-hydroxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C45H84O4 (688.6369264)


   

[1-hydroxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

[1-hydroxy-3-[(Z)-icos-11-enoxy]propan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C45H84O4 (688.6369264)


   

[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] (Z)-octadec-9-enoate

[1-hydroxy-3-[(13Z,16Z)-tetracosa-13,16-dienoxy]propan-2-yl] (Z)-octadec-9-enoate

C45H84O4 (688.6369264)


   

(1-hydroxy-3-tetradecoxypropan-2-yl) (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

(1-hydroxy-3-tetradecoxypropan-2-yl) (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

C45H84O4 (688.6369264)


   

[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] (Z)-henicos-11-enoate

[1-[(11Z,14Z)-henicosa-11,14-dienoxy]-3-hydroxypropan-2-yl] (Z)-henicos-11-enoate

C45H84O4 (688.6369264)


   

[1-[(Z)-docos-13-enoxy]-3-hydroxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

[1-[(Z)-docos-13-enoxy]-3-hydroxypropan-2-yl] (11Z,14Z)-icosa-11,14-dienoate

C45H84O4 (688.6369264)


   

[1-hydroxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] (Z)-tetradec-9-enoate

[1-hydroxy-3-[(17Z,20Z)-octacosa-17,20-dienoxy]propan-2-yl] (Z)-tetradec-9-enoate

C45H84O4 (688.6369264)


   

(1-hydroxy-3-octadecoxypropan-2-yl) (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

(1-hydroxy-3-octadecoxypropan-2-yl) (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

C45H84O4 (688.6369264)


   

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-hydroxypropan-2-yl] hexacosanoate

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-hydroxypropan-2-yl] hexacosanoate

C45H84O4 (688.6369264)


   

[1-hydroxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propan-2-yl] octadecanoate

[1-hydroxy-3-[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoxy]propan-2-yl] octadecanoate

C45H84O4 (688.6369264)


   

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] (Z)-hexacos-15-enoate

[1-[(9Z,12Z)-hexadeca-9,12-dienoxy]-3-hydroxypropan-2-yl] (Z)-hexacos-15-enoate

C45H84O4 (688.6369264)


   

[1-hydroxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

[1-hydroxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] (9Z,12Z)-octadeca-9,12-dienoate

C45H84O4 (688.6369264)


   

[1-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] tetracosanoate

[1-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] tetracosanoate

C45H84O4 (688.6369264)


   

[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] (Z)-docos-13-enoate

[1-hydroxy-3-[(11Z,14Z)-icosa-11,14-dienoxy]propan-2-yl] (Z)-docos-13-enoate

C45H84O4 (688.6369264)


   

[1-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] docosanoate

[1-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] docosanoate

C45H84O4 (688.6369264)


   

[1-[(15Z,18Z)-hexacosa-15,18-dienoxy]-3-hydroxypropan-2-yl] (Z)-hexadec-9-enoate

[1-[(15Z,18Z)-hexacosa-15,18-dienoxy]-3-hydroxypropan-2-yl] (Z)-hexadec-9-enoate

C45H84O4 (688.6369264)


   

[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] (Z)-tetracos-13-enoate

[1-hydroxy-3-[(9Z,12Z)-octadeca-9,12-dienoxy]propan-2-yl] (Z)-tetracos-13-enoate

C45H84O4 (688.6369264)


   

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

(1-hydroxy-3-tridecanoyloxypropan-2-yl) (14Z,17Z,20Z)-octacosa-14,17,20-trienoate

C44H80O5 (688.600543)


   

(1-hydroxy-3-undecanoyloxypropan-2-yl) (16Z,19Z,22Z)-triaconta-16,19,22-trienoate

(1-hydroxy-3-undecanoyloxypropan-2-yl) (16Z,19Z,22Z)-triaconta-16,19,22-trienoate

C44H80O5 (688.600543)


   

(1-heptadecanoyloxy-3-hydroxypropan-2-yl) (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

(1-heptadecanoyloxy-3-hydroxypropan-2-yl) (10Z,13Z,16Z)-tetracosa-10,13,16-trienoate

C44H80O5 (688.600543)


   

[17-[(E)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (11Z,14Z)-icosa-11,14-dienoate

[17-[(E)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (11Z,14Z)-icosa-11,14-dienoate

C48H80O2 (688.615798)


   

(1-hydroxy-3-pentadecanoyloxypropan-2-yl) (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

(1-hydroxy-3-pentadecanoyloxypropan-2-yl) (12Z,15Z,18Z)-hexacosa-12,15,18-trienoate

C44H80O5 (688.600543)


   

[17-[(E)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7E,9E)-nonadeca-7,9-dienoate

[17-[(E)-5-ethyl-6-methylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (7E,9E)-nonadeca-7,9-dienoate

C48H80O2 (688.615798)


   

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

[1-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (17Z,20Z)-octacosa-17,20-dienoate

C44H80O5 (688.600543)


   

[17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (10E,13E,16E)-nonadeca-10,13,16-trienoate

[17-(5-ethyl-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (10E,13E,16E)-nonadeca-10,13,16-trienoate

C48H80O2 (688.615798)


   

[17-(5,6-dimethylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (8Z,11Z,14Z)-icosa-8,11,14-trienoate

[17-(5,6-dimethylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (8Z,11Z,14Z)-icosa-8,11,14-trienoate

C48H80O2 (688.615798)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

[1-[(Z)-heptadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

[1-[(Z)-heptadec-9-enoyl]oxy-3-hydroxypropan-2-yl] (13Z,16Z)-tetracosa-13,16-dienoate

C44H80O5 (688.600543)


   

(1-hydroxy-3-nonadecanoyloxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate

(1-hydroxy-3-nonadecanoyloxypropan-2-yl) (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C44H80O5 (688.600543)


   

[1-hydroxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

[1-hydroxy-3-[(Z)-pentadec-9-enoyl]oxypropan-2-yl] (15Z,18Z)-hexacosa-15,18-dienoate

C44H80O5 (688.600543)


   

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropyl] (Z)-tetracos-13-enoate

[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropyl] (Z)-tetracos-13-enoate

C44H80O5 (688.600543)


   

[1-hydroxy-3-[(Z)-nonadec-9-enoyl]oxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

[1-hydroxy-3-[(Z)-nonadec-9-enoyl]oxypropan-2-yl] (13Z,16Z)-docosa-13,16-dienoate

C44H80O5 (688.600543)


   

[3-hydroxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] (Z)-henicos-11-enoate

[3-hydroxy-2-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] (Z)-henicos-11-enoate

C44H80O5 (688.600543)


   

[3-hydroxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropyl] henicosanoate

[3-hydroxy-2-[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]oxypropyl] henicosanoate

C44H80O5 (688.600543)


   

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-hydroxypropyl] pentacosanoate

[2-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]oxy-3-hydroxypropyl] pentacosanoate

C44H80O5 (688.600543)


   

[3-hydroxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] tricosanoate

[3-hydroxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]oxypropyl] tricosanoate

C44H80O5 (688.600543)


   

[1-hydroxy-3-[(Z)-icos-11-enoyl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

[1-hydroxy-3-[(Z)-icos-11-enoyl]oxypropan-2-yl] (11Z,14Z)-henicosa-11,14-dienoate

C44H80O5 (688.600543)


   

[3-hydroxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] (Z)-docos-13-enoate

[3-hydroxy-2-[(9Z,12Z)-nonadeca-9,12-dienoyl]oxypropyl] (Z)-docos-13-enoate

C44H80O5 (688.600543)


   

(1-hydroxy-3-nonanoyloxypropan-2-yl) (18Z,21Z,24Z)-dotriaconta-18,21,24-trienoate

(1-hydroxy-3-nonanoyloxypropan-2-yl) (18Z,21Z,24Z)-dotriaconta-18,21,24-trienoate

C44H80O5 (688.600543)


   

[1-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-hydroxypropan-2-yl] pentacosanoate

[1-[(9E,11E,13E)-hexadeca-9,11,13-trienoyl]oxy-3-hydroxypropan-2-yl] pentacosanoate

C44H80O5 (688.600543)


   

[(2S)-3-hydroxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (5E,9E)-hexacosa-5,9-dienoate

[(2S)-3-hydroxy-2-[(E)-pentadec-9-enoyl]oxypropyl] (5E,9E)-hexacosa-5,9-dienoate

C44H80O5 (688.600543)


   

[(2S)-1-hydroxy-3-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxypropan-2-yl] henicosanoate

[(2S)-1-hydroxy-3-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxypropan-2-yl] henicosanoate

C44H80O5 (688.600543)


   

[(2S)-3-hydroxy-2-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxypropyl] henicosanoate

[(2S)-3-hydroxy-2-[(8E,11E,14E)-icosa-8,11,14-trienoyl]oxypropyl] henicosanoate

C44H80O5 (688.600543)


   

[1-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-hydroxypropan-2-yl] (E)-pentacos-11-enoate

[1-[(4E,7E)-hexadeca-4,7-dienoyl]oxy-3-hydroxypropan-2-yl] (E)-pentacos-11-enoate

C44H80O5 (688.600543)


   

[(2S)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropyl] (E)-tetracos-15-enoate

[(2S)-2-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropyl] (E)-tetracos-15-enoate

C44H80O5 (688.600543)


   

[(2S)-3-hydroxy-2-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxypropyl] tricosanoate

[(2S)-3-hydroxy-2-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxypropyl] tricosanoate

C44H80O5 (688.600543)


   

[(2S)-1-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] (E)-tetracos-15-enoate

[(2S)-1-[(9E,12E)-heptadeca-9,12-dienoyl]oxy-3-hydroxypropan-2-yl] (E)-tetracos-15-enoate

C44H80O5 (688.600543)


   

[(2S)-1-hydroxy-3-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxypropan-2-yl] tricosanoate

[(2S)-1-hydroxy-3-[(9E,12E,15E)-octadeca-9,12,15-trienoyl]oxypropan-2-yl] tricosanoate

C44H80O5 (688.600543)


   

[(2S)-1-hydroxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (5E,9E)-hexacosa-5,9-dienoate

[(2S)-1-hydroxy-3-[(E)-pentadec-9-enoyl]oxypropan-2-yl] (5E,9E)-hexacosa-5,9-dienoate

C44H80O5 (688.600543)


   

1-Erucoyl-3-linoleoyl-sn-glycerol

1-Erucoyl-3-linoleoyl-sn-glycerol

C44H80O5 (688.600543)


   

ZyE(21:2)

ZyE(21:2)

C48H80O2 (688.615798)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

TG(41:3)

TG(12:0(1)_10:3_19:0)

C44H80O5 (688.600543)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

CmE(20:3)

CmE(20:3)

C48H80O2 (688.615798)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

ChE(21:3)

ChE(21:3)

C48H80O2 (688.615798)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

FAHFA 19:0/O-26:2

FAHFA 19:0/O-26:2

C45H84O4 (688.6369264)


   

FAHFA 19:1/O-26:1

FAHFA 19:1/O-26:1

C45H84O4 (688.6369264)


   

FAHFA 19:2/O-26:0

FAHFA 19:2/O-26:0

C45H84O4 (688.6369264)


   

FAHFA 20:0/O-25:2

FAHFA 20:0/O-25:2

C45H84O4 (688.6369264)


   

FAHFA 20:1/O-25:1

FAHFA 20:1/O-25:1

C45H84O4 (688.6369264)


   

FAHFA 20:2/O-25:0

FAHFA 20:2/O-25:0

C45H84O4 (688.6369264)


   

FAHFA 21:0/O-24:2

FAHFA 21:0/O-24:2

C45H84O4 (688.6369264)


   

FAHFA 21:1/O-24:1

FAHFA 21:1/O-24:1

C45H84O4 (688.6369264)


   

FAHFA 21:2/O-24:0

FAHFA 21:2/O-24:0

C45H84O4 (688.6369264)


   

FAHFA 22:0/O-23:2

FAHFA 22:0/O-23:2

C45H84O4 (688.6369264)


   

FAHFA 22:1/O-23:1

FAHFA 22:1/O-23:1

C45H84O4 (688.6369264)


   

FAHFA 22:2/O-23:0

FAHFA 22:2/O-23:0

C45H84O4 (688.6369264)


   

FAHFA 23:0/O-22:2

FAHFA 23:0/O-22:2

C45H84O4 (688.6369264)


   

FAHFA 23:1/O-22:1

FAHFA 23:1/O-22:1

C45H84O4 (688.6369264)


   

FAHFA 23:2/O-22:0

FAHFA 23:2/O-22:0

C45H84O4 (688.6369264)


   

FAHFA 24:0/O-21:2

FAHFA 24:0/O-21:2

C45H84O4 (688.6369264)


   

FAHFA 24:1/O-21:1

FAHFA 24:1/O-21:1

C45H84O4 (688.6369264)


   

FAHFA 24:2/O-21:0

FAHFA 24:2/O-21:0

C45H84O4 (688.6369264)


   

FAHFA 25:0/O-20:2

FAHFA 25:0/O-20:2

C45H84O4 (688.6369264)


   

FAHFA 25:1/O-20:1

FAHFA 25:1/O-20:1

C45H84O4 (688.6369264)


   

FAHFA 25:2/O-20:0

FAHFA 25:2/O-20:0

C45H84O4 (688.6369264)


   

FAHFA 26:0/O-19:2

FAHFA 26:0/O-19:2

C45H84O4 (688.6369264)


   

FAHFA 26:1/O-19:1

FAHFA 26:1/O-19:1

C45H84O4 (688.6369264)


   

FAHFA 26:2/O-19:0

FAHFA 26:2/O-19:0

C45H84O4 (688.6369264)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

7,12,16-trimethyl-15-(6-methyl-5-methylideneheptan-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl octadeca-9,12-dienoate

7,12,16-trimethyl-15-(6-methyl-5-methylideneheptan-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl octadeca-9,12-dienoate

C48H80O2 (688.615798)